Skip to main content

Advertisement

Log in

Valproate inhibits glucose-stimulated insulin secretion in beta cells

  • Short Communication
  • Published:
Histochemistry and Cell Biology Aims and scope Submit manuscript

Abstract

Valproate (VPA), an FDA approved anti-epileptic drug with a half-life of 12–18 h in humans, has been shown to perturb the vacuolar proton pump (vH+-ATPase) function in yeasts by inhibiting myo-inositol phosphate synthase, the first and rate-limiting enzyme in inositol biosynthesis, thereby resulting in inositol depletion. vH+-ATPase transfers protons (H+) across cell membranes, which help maintain pH gradients within cells necessary for various cellular functions including secretion. This proton pump has a membrane (V0) and a soluble cytosolic (V1) domain, with C-subunit associated with V1. In secretory cells such as neurons and insulin-secreting beta cells, vH+-ATPase acidifies vesicles essential for secretion. In this study, we demonstrate that exposure of insulin-secreting Min6 cells to a clinical dose of VPA results in inositol depletion and loss of co-localization of subunit C of vH+-ATPase with insulin-secreting granules. Consequently, a reduction of glucose-stimulated insulin secretion is observed following VPA exposure. These results merit caution and the reassessment of the clinical use of VPA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

Download references

Acknowledgements

Work presented in this article was supported in part by the National Science Foundation Grant CBET1066661 (BPJ); the WSU Interdisciplinary Biomedical Systems Fellowship (ARN); and R01 GM125082-05A1 from the National Institutes of Health (to M.L.G.). All authors critically analyzed results and proof read the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bhanu P. Jena.

Ethics declarations

Conflict of interest

The authors have nothing to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yedulla, N.R., Naik, A.R., Kokotovich, K.M. et al. Valproate inhibits glucose-stimulated insulin secretion in beta cells. Histochem Cell Biol 150, 395–401 (2018). https://doi.org/10.1007/s00418-018-1713-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00418-018-1713-6

Keywords

Navigation